This week James is joined by Pharmacy2U’s CEO, Mark Livingstone, to discuss his epic career.
In October 2018, we started The HS. Health-Tech Podcast. The goal was to connect everyone in healthtech from around the world and to spread the best insights from our own learning and from successful entrepreneurs. Through 2019 it grew rapidly. We saw almost 20% week-on-week growth, and listeners went from solely in the UK to 84 different countries. Here are 5 things I've learned from hosting:
This week, James is joined by Natalie Douglas, who has over 20 years of experience in the pharmaceutical industry and healthcare services sector.
Wednesday September 25 saw the U.K. launch of a device that has the potential to change the way ultrasound scans are performed. Already, the company has raised $250 million investment at a $1.25 billion valuation from the likes of The Bill and Melinda Gates Foundation, Fidelity and Fosun Pharma, demonstrating their global intent.
When the gifted hands make a mistake — Surgical errors and the urgent need to invest in patient safety
In this guest blog by Yesh, founder of our portfolio company, Scalpel, we delve into the world of surgery and surgical safety. Yesh explores his passions for surgery and how he combined his skills to start the computer vision company to make surgery faster and safer.
James is joined by Dr. Jud Brewer who holds the position of 4th most-watched TED talk ever, with 12 million views. Jud is the founder of MindSciences Inc developing digital therapeutics in the area of addiction, he is Director of Research and Innovation at the Mindfulness Center and associate professor in psychiatry at the School of Medicine at Brown University and research affiliate at MIT.
HS. cofounder James Somauroo's latest for Forbes: This week, Fitbit (NYSE: FIT) announced that it will be collaborating with Singapore’s government to provide their 5.6 million population with fitness trackers in a nationwide public health initiative.
HS. cofounder Dr. James Somauroo's latest for Forbes: A new report by consulting firm EY suggests that if the U.K. National Health Service (NHS) datasets were put to use, their value could be up to £9.6 billion ($12 billion) per year.
James is joined by Dr. Paul-Peter Tak, Venture Partner at Flagship Pioneering and CEO of Kintai Therapeutics. Over a more than 25-year career in the life sciences, Paul-Peter has created and led multiple companies. From 2011 until 2017, Paul-Peter founded and served as senior vice president and head of the immuno-inflammation therapy area unit at GSK.
HS. portfolio company Feebris has announced a successful seed investment raise of £1.1 million. The funding enables the company to continue its innovation in AI for precision diagnosis of respiratory conditions in elderly patients in the UK and young children in India.
James is joined by Mir Imran, an Indian healthtech inventor, entrepreneur and venture capitalist who has had >20 device companies, >400 patents and has sold companies to the likes of Ely Lily and Medtronic.
In association with the UK Business Angels Association and British Venture Capital Association, HS. presented a fantastic investor only Investor Summit - a half-day educational event focusing on industry trends, investment opportunities and look ahead at what emerging technologies will shape the sector.